TrialCurrent medical research and opinion2014

Long-term efficacy and safety of canagliflozin monotherapy in patients with type 2 diabetes inadequately controlled with diet and exercise: findings from the 52-week CANTATA-M study.

Kaj Stenlöf et al.PubMed ↗Publisher ↗

No numbers read from the abstract.